PANA Realtyper™ HPV screening kit is a medical device for in-vitro diagnostic analysis that is qualitatively detected by real-time PCR. A single test can detect 14 high-risk groups of HPV (Genotyping 16,18 / Screening 31,33,35,39,45,51,52,56,58,59,66,68), two major risk factors for cervical cancer, and 2 low-risk groups (Genotyping 6,11) for vaccine prescription